Niacin ER
Class
Dietary supplements
Subclass
Vitamins
Substance name
Niacin, nicotinic acid ER
Common formulations
Tablet
See also
Niacin (Niacor®)
Dosage and administration
Adults patients
Treatment
Mixed hyperlipidemia
Primary hyperlipidemia
Adjunctive treatment
Adjunctive treatment for coronary artery disease in patients with hyperlipidemia
Secondary prevention
Secondary prevention of myocardial infarction in patients with hyperlipidemia
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
Hypersensitivity to niacin or its components
Active peptic ulcer disease
Arterial bleeding
Warnings and precautions
Cardiovascular mortality
Decreased platelet count, prolonged PT
Decreased serum phosphate
Exacerbation of increased blood glucose
Exacerbation of skin flushing
Hepatotoxicity
Increased urine uric acid
Rhabdomyolysis
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Substantial chronic alcohol consumption
Unexplained abnormality in LFTs
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B2
Breastfeeding
Do not use during breastfeeding.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
May potentially cause adverse effects in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource